Arkolith/Insider Trading/AGTC/Form 4

Lieber Jonathan I

Chief Financial OfficerAPPLIED GENETIC TECHNOLOGIES CORP (AGTC) · full profile →Form 4 · filed Dec 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 30, 2022Disposed to issuer(D)155K——0
Nov 30, 2022Disposed to issuer(D)202K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-22-023018) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML